Total Payments
$81,669
2024 Payments
$15,409
Companies
8
Transactions
51
Medicare Patients
1,491
Medicare Billing
$17,432
Payment Breakdown by Category
Consulting$71,406 (87.4%)
Education$4,085 (5.0%)
Other$3,326 (4.1%)
Research$2,487 (3.0%)
Food & Beverage$364.82 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $71,406 | 20 | 87.4% |
| Education | $4,085 | 10 | 5.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,326 | 11 | 4.1% |
| Unspecified | $2,487 | 6 | 3.0% |
| Food and Beverage | $364.82 | 4 | 0.4% |
Payments by Type
General
$79,182
45 transactions
Research
$2,487
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $21,298 | 8 | $0 (2020) |
| Radius Health, Inc. | $18,139 | 26 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $13,974 | 7 | $0 (2021) |
| Ultragenyx Pharmaceutical Inc. | $12,820 | 4 | $0 (2024) |
| AstraZeneca AB | $8,370 | 2 | $0 (2024) |
| SANOFI US SERVICES INC. | $4,368 | 1 | $0 (2021) |
| Agios Pharmaceuticals, Inc. | $1,375 | 1 | $0 (2023) |
| Biocon Biologics Inc | $1,325 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,409 | 15 | AstraZeneca AB ($6,510) |
| 2023 | $7,232 | 9 | Radius Health, Inc. ($3,997) |
| 2022 | $6,592 | 6 | Ultragenyx Pharmaceutical Inc. ($4,050) |
| 2021 | $10,942 | 4 | Ultragenyx Pharmaceutical Inc. ($4,500) |
| 2020 | $11,213 | 4 | Radius Health, Inc. ($5,773) |
| 2019 | $16,863 | 4 | Amgen Inc. ($16,841) |
| 2018 | $13,234 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($10,710) |
| 2017 | $183.06 | 3 | Amgen Inc. ($183.06) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $288.89 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $590.22 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $35.00 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | Biocon Biologics Inc | — | — | Cash or cash equivalent | $550.00 | Research |
| Study: DEVOTE | ||||||
| 09/20/2024 | Ultragenyx Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $4,248.00 | General |
| 08/26/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $317.67 | General |
| Category: Endocrinology | ||||||
| 08/16/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $249.44 | General |
| Category: Endocrinology | ||||||
| 07/29/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $121.00 | General |
| Category: Endocrinology | ||||||
| 07/24/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $468.11 | General |
| Category: Endocrinology | ||||||
| 06/27/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $222.22 | General |
| Category: Endocrinology | ||||||
| 06/10/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $364.11 | General |
| Category: Endocrinology | ||||||
| 05/16/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $233.11 | General |
| Category: Endocrinology | ||||||
| 05/02/2024 | Biocon Biologics Inc | — | — | Cash or cash equivalent | $775.00 | Research |
| Study: DEVOTE | ||||||
| 02/29/2024 | Radius Health, Inc. | Tymlos (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $436.50 | General |
| Category: Endocrinology | ||||||
| 01/15/2024 | AstraZeneca AB | TEZSPIRE (Biological) | Consulting Fee | Cash or cash equivalent | $6,510.00 | General |
| Category: Respiratory | ||||||
| 12/14/2023 | Radius Health, Inc. | — | Education | In-kind items and services | $225.22 | General |
| 12/08/2023 | AstraZeneca AB | — | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| 12/08/2023 | Radius Health, Inc. | — | Education | In-kind items and services | $571.22 | General |
| 11/22/2023 | Radius Health, Inc. | — | Education | In-kind items and services | $302.00 | General |
| 10/31/2023 | Radius Health, Inc. | — | Education | In-kind items and services | $1,373.33 | General |
| 10/20/2023 | Radius Health, Inc. | — | Education | In-kind items and services | $187.22 | General |
| 05/31/2023 | Radius Health, Inc. | Tymlos (Drug) | Education | In-kind items and services | $1,318.75 | General |
| Category: Endocrinology | ||||||
| 02/15/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: Genetically Defined Disease | ||||||
| 01/15/2023 | Radius Health, Inc. | Tymlos (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: Endocrinology | ||||||
| 12/15/2022 | Radius Health, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,380.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DEVOTE | Biocon Biologics Inc | $1,325 | 2 |
| The Safety and Efficacy of Abaloparatide-SC in Men with Osteoporosis: A Randomized Clinical Trial | Radius Health, Inc. | $925.32 | 3 |
| Efficacy and Safety of Abaloparatide in Men with Osteoporosis | Radius Health, Inc. | $236.25 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 435 | 436 | $17,114 | $5,799 |
| 2022 | 2 | 427 | 428 | $15,151 | $5,289 |
| 2021 | 1 | 350 | 350 | $8,400 | $3,498 |
| 2020 | 1 | 279 | 279 | $6,696 | $2,846 |
Total Patients
1,491
Total Services
1,493
Medicare Billing
$17,432
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 419 | 419 | $10,056 | $4,043 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 17 | $7,058 | $1,756 | 24.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2022 | 415 | 415 | $9,960 | $4,094 | 41.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 13 | $5,191 | $1,195 | 23.0% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Facility | 2021 | 350 | 350 | $8,400 | $3,498 | 41.6% |
| 77080 | Bone density measurement using dedicated x-ray machine | Facility | 2020 | 279 | 279 | $6,696 | $2,846 | 42.5% |
About Dr. Eric Orwoll, MD
Dr. Eric Orwoll, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083629570.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Orwoll, MD has received a total of $81,669 in payments from pharmaceutical and medical device companies, with $15,409 received in 2024. These payments were reported across 51 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($71,406).
As a Medicare-enrolled provider, Orwoll has provided services to 1,491 Medicare beneficiaries, totaling 1,493 services with total Medicare billing of $17,432. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Portland, OR
- Active Since 07/31/2006
- Last Updated 07/23/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1083629570
Products in Payments
- Prolia (Biological) $21,064
- Nexavar (Drug) $10,710
- TEZSPIRE (Biological) $6,510
- Tymlos (Drug) $4,665
- Non-Covered $3,264
- PYRUKYND (Drug) $1,375
- Tymlos (Biological) $1,162
- EVENITY (Biological) $91.35
- CRYSVITA (Drug) $21.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Portland
Mr. Michael Mcclung, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.6M
Endocrinology, Diabetes & Metabolism $1.6M
James Neifing, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $475,019
Endocrinology, Diabetes & Metabolism $475,019
Maria Fleseriu, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $418,716
Endocrinology, Diabetes & Metabolism $418,716
Rodica Busui, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $211,479
Endocrinology, Diabetes & Metabolism $211,479
Jonathan Purnell, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $209,631
Endocrinology, Diabetes & Metabolism $209,631
Nancy Curosh, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $194,307
Endocrinology, Diabetes & Metabolism $194,307